Advanced search
Publication Cover
Clinical Epidemiology Volume 12, 2020 - Issue
Submit an article Journal homepage
141
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Concordance Between ICD-10 Codes and Clinical Diagnosis of Hypoparathyroidism in Sweden

Wafa Kamal1 Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden;2 Department of Medicine, Capio Sankt Görans Hospital, Stockholm, SwedenCorrespondence[email protected]
,
Sigridur Björnsdottir1 Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden;3 Department of Endocrinology, Karolinska University Hospital, Stockholm, Sweden
,
Olle Kämpe3 Department of Endocrinology, Karolinska University Hospital, Stockholm, Sweden;4 Department of Medicine (Solna), Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden;5 K.G. Jebsen Center for Autoimmune Diseases, University of Bergen, Bergen, NorwayORCID Iconhttps://orcid.org/0000-0001-6091-9914
ORCID Icon &
Ylva Trolle Lagerros6 Clinical Epidemiology Division, Department of Medicine, Karolinska Institutet, Stockholm, Sweden;7 Obesity Center, Academic Specialist Center, Stockholm Health Services, Stockholm, SwedenORCID Iconhttps://orcid.org/0000-0001-6816-7577
ORCID Icon
Pages 327-331 | Published online: 24 Mar 2020

References

  • Clarke BL, Brown EM, Collins MT, et al. Epidemiology and Diagnosis of Hypoparathyroidism. J Clin Endocrinol Metab. 2016;101(6):2284–2299. doi:10.1210/jc.2015-390826943720
  • Astor MC, Lovas K, Debowska A, et al. Epidemiology and Health-Related Quality of Life in Hypoparathyroidism in Norway. J Clin Endocrinol Metab. 2016;101(8):3045–3053. doi:10.1210/jc.2016-147727186861
  • Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L. Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study. J Bone Miner Res. 2013;28(11):2277–2285. doi:10.1002/jbmr.197923661265
  • Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L. The Epidemiology of Nonsurgical Hypoparathyroidism in Denmark: a Nationwide Case Finding Study. J Bone Miner Res. 2015;30(9):1738–1744. doi:10.1002/jbmr.v30.925753591
  • Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L. Pseudohypoparathyroidism - epidemiology, mortality and risk of complications. Clin Endocrinol (Oxf). 2016;84(6):904–911. doi:10.1111/cen.1294826387561
  • Cianferotti L, Parri S, Gronchi G, et al. Prevalence of Chronic Hypoparathyroidism in a Mediterranean Region as Estimated by the Analysis of Anonymous Healthcare Database. Calcif Tissue Int. 2018;103(2):144–150. doi:10.1007/s00223-018-0405-529516129
  • Cipriani C, Pepe J, Biamonte F, et al. The Epidemiology of Hypoparathyroidism in Italy: an 8-Year Register-Based Study. Calcif Tissue Int. 2017;100(3):278–285. doi:10.1007/s00223-016-0222-728012105
  • Bilezikian JP, Khan A, Potts JT Jr, et al. Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J Bone Miner Res. 2011;26(10):2317–2337. doi:10.1002/jbmr.v26.1021812031
  • Al-Azem H, Khan AA. Hypoparathyroidism. Best Pract Res Clin Endocrinol Metab. 2012;26(4):517–522. doi:10.1016/j.beem.2012.01.00422863393
  • Husebye ES, Anderson MS, Kampe O. Autoimmune Polyendocrine Syndromes. N Engl J Med. 2018;378(26):2543–2544. doi:10.1056/NEJMra1713301
  • Brandi ML, Bilezikian JP, Shoback D, et al. Management of Hypoparathyroidism: summary Statement and Guidelines. J Clin Endocrinol Metab. 2016;101(6):2273–2283. doi:10.1210/jc.2015-390726943719
  • Shoback DM, Bilezikian JP, Costa AG, et al. Presentation of Hypoparathyroidism: etiologies and Clinical Features. J Clin Endocrinol Metab. 2016;101(6):2300–2312. doi:10.1210/jc.2015-390926943721
  • Bilezikian JP, Brandi ML, Cusano NE, et al. Management of Hypoparathyroidism: present and Future. J Clin Endocrinol Metab. 2016;101(6):2313–2324. doi:10.1210/jc.2015-391026938200
  • Cusano NE, Rubin MR, Irani D, Sliney J Jr, Bilezikian JP. Use of parathyroid hormone in hypoparathyroidism. J Endocrinol Invest. 2013;36(11):1121–1127. doi:10.1007/BF0334676324445125
  • Moe SM. Disorders involving calcium, phosphorus, and magnesium. Prim Care. 2008;35(2):215–237, v–vi. doi:10.1016/j.pop.2008.01.007
  • Bollerslev J, Rejnmark L, Marcocci C, et al. European Society of Endocrinology Clinical Guideline: treatment of chronic hypoparathyroidism in adults. Eur J Endocrinol. 2015;173(2):G1–G20. doi:10.1530/EJE-15-062826160136
  • Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11(1):450. doi:10.1186/1471-2458-11-45021658213
  • Lunde AS, Lundeborg S, Lettenstrom GS, Thygesen L, Huebner J. The person-number systems of Sweden, Norway, Denmark, and Israel. Vital Health Stat 2 (84);1980:1–59.
  • Wettermark B, Hammar N, Fored CM, et al. The new Swedish Prescribed Drug Register–opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2007;16(7):726–735. doi:10.1002/(ISSN)1099-155716897791
  • Socialstyrelsen (The Swedish National Board of Health and Welfare). Läkemedelsregistret;10 18, 2019 Available from:https://www.socialstyrelsen.se/statistik-och-data/register/alla-register/lakemedelsregistret/. Accessed 310, 2020.
  • Sikjaer T, Rejnmark L, Rolighed L, Heickendorff L, Mosekilde L, Hypoparathyroid Study G. The effect of adding PTH(1–84) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled study. J Bone Miner Res. 2011;26(10):2358–2370. doi:10.1002/jbmr.47021773992
  • Adami S, Marcocci C, Gatti D. Epidemiology of primary hyperparathyroidism in Europe. J Bone Miner Res. 2002;17(Suppl 2):N18–N23.12412773

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.